- All
- Important
- Financial Update
- Fund Raise
- Board Meeting
- Dividend/Bonus
- JV/Acquisition
- Investor Meet
- Insider Trade
- Pledging
- Others
Dr. Reddy's Laboratories Limited — Important, 10-09-2025: Arrangements for strategic, technical, manufacturing, or marketing tie up
10-09-2025 | 11:24 pm
10-09-2025 | 11:24 pm
Dr. Reddy's acquires STUGERON® portfolio from Johnson & Johnson's Janssen Pharmaceutica NV for USD 50.5 million. This strategic move strengthens Dr. Reddy's CNS offering and expands its anti-vertigo market presence across 18 APAC/EMEA regions, including key markets India and Vietnam.
No comments yet. Be the first to comment!